Myelin oligodendrocyte glycoprotein: can it predict specific neurological conditions?

High titers of antibodies against myelin oligodendrocyte glycoprotein (MOG) may help identify patients with certain neurological disorders, researcher say.

Previous studies have found associations between the presence of MOG antibodies (MOG-Ab) and numerous neurological disorders, such as neuromyelitis optica spectrum disorder (NMOSD) in adults and acute disseminated encephalomyelitis in children.